Fingerprint
Dive into the research topics of 'Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing
H. B. Koon, P. Severy, D. S. Hagg, K. Butler, T. Hill, A. G. Jones, T. A. Waldmann, R. P. Junghans
Research output: Contribution to journal › Article › peer-review
31
Scopus
citations